Key result
Essential amino acid supplementation is linked to ~40% better GLS in sarcopenic HFrEF.
Why the study?
Does essential amino acid supplementation improve cardiac and muscular performance in elderly patients with HFrEF and sarcopenia?
Population
60 Caucasian patients with heart failure with reduced ejection fraction, NYHA class II and class III, and…
Design
Cohort
Follow-up
6 months
Authors
Loading...
Early effects of essential amino acid supplementation improve cardiac and muscle performance in heart failure and sarcopenia patients, suggesting potential therapeutic benefits.
Does essential amino acid supplementation improve cardiac and muscular performance in elderly patients with HFrEF and sarcopenia?
Absolute Event Rate: -11.9% vs -8.5%
p-value: p=<0.0001
Armentaro et al. (2025) studied Heart failure with reduced ejection fraction (HFrEF) and sarcopenia (n=60). Essential amino acid supplementation was evaluated on Changes in Global Longitudinal Strain (GLS) (p=<0.0001). Essential amino acid supplementation for 6 months in elderly patients with HFrEF and sarcopenia significantly improved Global Longitudinal Strain (from -8.5% to -11.9%, P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: